Literature DB >> 8179197

Release of proteins and peptides from fusion proteins using a recombinant plant virus proteinase.

T D Parks1, K K Leuther, E D Howard, S A Johnston, W G Dougherty.   

Abstract

An improved method for the production, cleavage, and purification of fusion proteins and peptides is described. The unique aspect of this method is dependent on the use of a proteinase from tobacco etch virus (TEV). The proteinase used is a recombinant TEV proteinase produced with a polyhistidine tract positioned at the amino terminus. The proteinase recognizes a specific, extended cleavage site sequence. The peptide or protein of interest is purified as a fusion protein with a TEV proteinase cleavage site sequence located between it and an affinity carrier portion of the fusion. Incubation with the recombinant TEV proteinase mediates release of the peptide or protein of interest. Use of the recombinant TEV proteinase to cleave fusion proteins is an improvement over use of other proteinases for several reasons, including its high degree of specificity, its insensitivity to many proteinase inhibitors generally used in protein purification, and the ready separation of both the affinity tag and the proteinase from the cleaved product of interest.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8179197     DOI: 10.1006/abio.1994.1060

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  89 in total

1.  The winged-helix/forkhead protein myocyte nuclear factor beta (MNF-beta) forms a co-repressor complex with mammalian sin3B.

Authors:  Q Yang; Y Kong; B Rothermel; D J Garry; R Bassel-Duby; R S Williams
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

2.  TAP binds to the constitutive transport element (CTE) through a novel RNA-binding motif that is sufficient to promote CTE-dependent RNA export from the nucleus.

Authors:  I C Braun; E Rohrbach; C Schmitt; E Izaurralde
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

3.  The interaction of titin and alpha-actinin is controlled by a phospholipid-regulated intramolecular pseudoligand mechanism.

Authors:  P Young; M Gautel
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

4.  Transient expression of a winged-helix protein, MNF-beta, during myogenesis.

Authors:  Q Yang; R Bassel-Duby; R S Williams
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

5.  Differential effects of supplementary affinity tags on the solubility of MBP fusion proteins.

Authors:  Karen M Routzahn; David S Waugh
Journal:  J Struct Funct Genomics       Date:  2002

6.  (1)H/(15)N heteronuclear NMR spectroscopy shows four dynamic domains for phospholamban reconstituted in dodecylphosphocholine micelles.

Authors:  Emily E Metcalfe; Jamillah Zamoon; David D Thomas; Gianluigi Veglia
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

7.  An expression and purification system for the biosynthesis of adenosine receptor peptides for biophysical and structural characterization.

Authors:  Zachary T Britton; Elizabeth I Hanle; Anne S Robinson
Journal:  Protein Expr Purif       Date:  2012-06-19       Impact factor: 1.650

8.  Activation of specific apoptotic caspases with an engineered small-molecule-activated protease.

Authors:  Daniel C Gray; Sami Mahrus; James A Wells
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

9.  Crystallization and preliminary X-ray crystallographic analysis of MbtI, a protein essential for siderophore biosynthesis in Mycobacterium tuberculosis.

Authors:  Anthony J Harrison; Rochelle J Ramsay; Edward N Baker; J Shaun Lott
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2004-12-24

10.  Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking.

Authors:  Chavdar Krachmarov; Abraham Pinter; William J Honnen; Miroslaw K Gorny; Phillipe N Nyambi; Susan Zolla-Pazner; Samuel C Kayman
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.